Results 191 to 200 of about 12,091 (224)

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Ca-A Cancer Journal for Clinicians, 2021
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel   +2 more
exaly  

Cancer statistics, 2023

Ca-A Cancer Journal for Clinicians, 2023
Rebecca L Siegel, Kimberly D Miller, Nikita Sandeep Wagle   +2 more
exaly  

Drug-induced liver injury (DILI)

2012
Russmann, Stefan, Kullak-Ublick, Gerd Achim   +1 more
openaire   +1 more source

S1203 When Is Suspected Drug Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases from the U.S. Drug Induced Liver Injury Network (DILIN)

American Journal of Gastroenterology, 2022
Alfred S. Barritt, Huiman Barnhart, Sean Rudnick, Paola Nicoletti, Herbert Bonkovsky   +4 more
openaire   +1 more source

Onconephrology: The intersections between the kidney and cancer

Ca-A Cancer Journal for Clinicians, 2021
, Kenar D Jhaveri, Mark A Perazella
exaly  

Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians

Ca-A Cancer Journal for Clinicians, 2023
Demetrios Moris
exaly  

Health insurance status and cancer stage at diagnosis and survival in the United States

Ca-A Cancer Journal for Clinicians, 2022
Jingxuan Zhao, Xuesong Han, Leticia M Nogueira   +2 more
exaly  

Drug-induced liver injury: importance, epidemiology, and mechanisms of DILI

The Biomedical & Life Sciences Collection, 2021
openaire   +1 more source

Immunotherapies for hepatocellular carcinoma

Nature Reviews Clinical Oncology, 2021
, Florian Castet, Mala K Maini
exaly  

Drug-induced liver injury: HDS, diagnosing, treating and preventing DILI

The Biomedical & Life Sciences Collection, 2021
openaire   +1 more source